Skip to content

Clinical trials

Withdrawn Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Withdrawn Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20102
20112
20123
20131
20142
20151
20161
20171
20181
20192
20202
20222
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lee Moffitt Cancer Center and Research Institute2
Alan Katz1
Bastyr University1
Cornerstone Pharmaceuticals1
Dana-Farber Cancer Institute1
Eurofarma Laboratorios S.A.1
Imunon1
Institut Cancerologie de l'Ouest1
Medical College of Wisconsin1
Molecular Insight Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma26
Neoplasm Metastasis6
Neoplasms5
Pancreatic Neoplasms4
Stomach Neoplasms4
Carcinoma3
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Prostatic Neoplasms3
Carcinoma, Squamous Cell2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.